ArticleImmuno-oncology technology2025

Challenges and opportunities of predicting overall survival benefit from improvements to recurrence-free survival in stage II/III melanoma: a correlation meta-analysis.

L Leung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.